{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:05Z","timestamp":1786118645131,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/gme.0b013e31804d440b","type":"journal-article","created":{"date-parts":[[2007,4,4]],"date-time":"2007-04-04T04:07:27Z","timestamp":1175659647000},"page":"352-354","source":"Crossref","is-referenced-by-count":2,"title":["Drospirenone, a progestin with added value for hypertensive postmenopausal women"],"prefix":"10.1097","volume":"14","author":[{"given":"David F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210227","first-page":"B60","article-title":"Cholesterol, lipoproteins, and coronary heart disease in women.","volume":"34","author":"Bush","year":"1988","journal-title":"Clin Chem"},{"key":"R3-6-20210227","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.CIR.83.4.1287","article-title":"Screening for total cholesterol. Do the National Cholesterol Education Program's recommendations detect individuals at high risk of coronary heart disease?","volume":"83","author":"Bush","year":"1991","journal-title":"Circulation"},{"key":"R4-6-20210227","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-89-2-157","article-title":"Menopause and coronary heart disease. The Framingham Study.","volume":"89","author":"Gordon","year":"1978","journal-title":"Ann Intern Med"},{"key":"R5-6-20210227","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"R6-6-20210227","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/archinte.1993.00410190045006","article-title":"Plasma lipoprotein levels as predictors of cardiovascular death in women.","volume":"153","author":"Bass","year":"1993","journal-title":"Arch Intern Med"},{"key":"R7-6-20210227","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"Hormone replacement therapy, heart disease, and other considerations.","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annu Rev Public Health"},{"issue":"Suppl","key":"R8-6-20210227","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/0021-9150(95)90068-3","article-title":"Postmenopausal estrogen and heart disease.","volume":"118","author":"Barrett-Connor","year":"1995","journal-title":"Atherosclerosis"},{"key":"R9-6-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R10-6-20210227","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease.","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"R11-6-20210227","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R12-6-20210227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMsb022365","article-title":"Understanding the divergent data on postmenopausal hormone therapy.","volume":"348","author":"Grodstein","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-6-20210227","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system.","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"R14-6-20210227","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.fertnstert.2004.02.095","article-title":"The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.","volume":"81","author":"Naftolin","year":"2004","journal-title":"Fertil Steril"},{"key":"R15-6-20210227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health (Larchmt)"},{"key":"R16-6-20210227","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"R17-6-20210227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.273.3.199","article-title":"The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R18-6-20210227","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0039-128X(03)00123-5","article-title":"MPA and postmenopausal coronary artery atherosclerosis revisited.","volume":"68","author":"Clarkson","year":"2003","journal-title":"Steroids"},{"key":"R19-6-20210227","first-page":"41","article-title":"Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens.","volume":"86","author":"Clarkson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-6-20210227","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.maturitas.2005.02.016","article-title":"Controversies about HRT-lessons from monkey models.","volume":"51","author":"Clarkson","year":"2005","journal-title":"Maturitas"},{"key":"R21-6-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/Progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"R22-6-20210227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-005-0096-0","article-title":"The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial.","volume":"49","author":"Bonds","year":"2006","journal-title":"Diabetologia"},{"key":"R23-6-20210227","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"R24-6-20210227","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002512-200320040-00004","article-title":"Prevalence and implications of uncontrolled systolic hypertension.","volume":"20","author":"Kannel","year":"2003","journal-title":"Drugs Aging"},{"issue":"7","key":"R25-6-20210227","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMcp010357","article-title":"Initial treatment of hypertension.","volume":"348","author":"August","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-6-20210227","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R27-6-20210227","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.gme.0000243572.63322.f7","article-title":"Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.","volume":"14","author":"Preston","year":"2007","journal-title":"Menopause"},{"key":"R28-6-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone. A progestogen with antimineralocorticoid properties: a short review.","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"R29-6-20210227","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/09513590009167683","article-title":"Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.","volume":"14","author":"Oelkers","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"R30-6-20210227","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure.","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"R31-6-20210227","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in hormonal replacement therapy: new molecules, risks, and benefits.","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"issue":"Suppl 3","key":"R32-6-20210227","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","article-title":"Pharmacology of different progestogens: the special case of drospirenone.","volume":"8","author":"Sitruk-Ware","year":"2005","journal-title":"Climacteric"},{"key":"R33-6-20210227","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension.","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"R34-6-20210227","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000232179.60442.84","article-title":"Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.","volume":"48","author":"White","year":"2006","journal-title":"Hypertension"},{"key":"R35-6-20210227","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0895-7061(02)02980-1","article-title":"Additive effect of drospirenone\/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.","volume":"15","author":"Preston","year":"2002","journal-title":"Am J Hypertens"},{"key":"R36-6-20210227","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjhyper.2004.12.003","article-title":"Effects of drospirenone\/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.","volume":"18","author":"Preston","year":"2005","journal-title":"Am J Hypertens"},{"key":"R37-6-20210227","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200714030-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:36:23Z","timestamp":1786034183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200714030-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31804d440b","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}